)
Damon R. Race
CEO
GeneVentiv Therapeutics, Inc.
Damon Race is President and Chief Executive Officer of GeneVentiv Therapeutics, where he leads corporate strategy and the advancement of the company’s product candidates. He brings over 30 years of experience spanning commercial pharmaceuticals and private investment.
Mr. Race earned a B.S. in Biology from George Mason University and an MBA from Duke University’s Fuqua School of Business. He holds the Certified Licensing Professional® designation from the Licensing Executive Society, is a Chartered Market Technician® charterholder, and holds the FINRA Series 65. He also serves in multiple board, advisory, and volunteer roles.
Sessions
-
24-Jun-2026Theater 3GeneVentiv Therapeutics, Inc.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}